Equels Thomas Kinsider trades
In SEC Form 4 filings, Equels Thomas K is listed as CEO & President of AIM ImmunoTech Inc. (AIM). In the last 90 days, Equels Thomas K bought $18.5K of AIM ImmunoTech Inc. (AIM) on the open market and sold none. The largest purchase was $5.1K of AIM ImmunoTech Inc. (AIM) on Oct 22.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| AIMAIM ImmunoTech Inc. | CEO & President | 5 | Oct 23 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-15
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| AIMAIM ImmunoTech Inc. | Oct 22 | Oct 23 | P | 31,250 | $0.16 | Purchase +$5,094 | 158,072 | No | Form 4 |
| AIMAIM ImmunoTech Inc. | Sep 17 | Sep 18 | P | 24,000 | $0.21 | Purchase +$4,992 | 126,822 | No | Form 4 |
| AIMAIM ImmunoTech Inc. | Sep 16 | Sep 17 | P | 11,000 | $0.21 | Purchase +$2,310 | 102,822 | No | Form 4 |
| AIMAIM ImmunoTech Inc. | Sep 15 | Sep 16 | P | 22,000 | $0.22 | Purchase +$4,862 | 91,822 | No | Form 4 |
| AIMAIM ImmunoTech Inc. | Sep 14 | Sep 15 | P | 5,900 | $0.22 | Purchase +$1,292 | 69,822 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.